Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.77 USD | +3.39% |
|
+15.28% | +34.60% |
15/07 | Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating | MT |
01/07 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell Small Cap Comp Value Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.60% | 111.48Cr | |
+11.41% | 1.73TCr | |
0.00% | 902.42Cr | |
-21.69% | 256.41Cr | |
-23.62% | 232.94Cr | |
-23.43% | 193.16Cr | |
-18.96% | 93Cr | |
-0.21% | 75Cr | |
-32.02% | 63Cr | |
-37.60% | 55Cr |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Transcript : Core Laboratories N.V., Q4 2016 Earnings Call, Jan 26, 2017